The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
The global Veterinary Vaccines market was valued at US$ 8304 million in 2023 and is anticipated to reach US$ 12680 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry.
According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 106%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Vaccines.
Report Scope
The Veterinary Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Elanco
- Merck
- Merial
- Zoetis
- Advaxis
- AmpliPhi Biosciences
- Aratana Therapeutics
- ARKO Labs
- Bayer
- CanFel Therapeutics
- Ceva Animal Health
- Colorado Serum
- Epitopix
- Genus
- Hygieia Biological Laboratories
- ImmuCell
- Nexvet
- Nuovo Biologics
- UBI
- Valneva
- Vetoquinol
- Virbac
Segment by Type
- Inactivated Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- DNA Vaccines
- Others
Segment by Application
- Veterinary Clinic
- Veterinary Hospital
- Veterinary Research Institute
- Retail Pharmacy
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 DNA Vaccines
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccines Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Vaccines Market Perspective (2019-2030)
2.2 Veterinary Vaccines Growth Trends by Region
2.2.1 Global Veterinary Vaccines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Vaccines Historic Market Size by Region (2019-2024)
2.2.3 Veterinary Vaccines Forecasted Market Size by Region (2025-2030)
2.3 Veterinary Vaccines Market Dynamics
2.3.1 Veterinary Vaccines Industry Trends
2.3.2 Veterinary Vaccines Market Drivers
2.3.3 Veterinary Vaccines Market Challenges
2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Vaccines Players by Revenue
3.1.1 Global Top Veterinary Vaccines Players by Revenue (2019-2024)
3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2019-2024)
3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
3.4 Global Veterinary Vaccines Market Concentration Ratio
3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2023
3.5 Veterinary Vaccines Key Players Head office and Area Served
3.6 Key Players Veterinary Vaccines Product Solution and Service
3.7 Date of Enter into Veterinary Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
4.1 Global Veterinary Vaccines Historic Market Size by Type (2019-2024)
4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2025-2030)
5 Veterinary Vaccines Breakdown Data by Application
5.1 Global Veterinary Vaccines Historic Market Size by Application (2019-2024)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Vaccines Market Size (2019-2030)
6.2 North America Veterinary Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Vaccines Market Size by Country (2019-2024)
6.4 North America Veterinary Vaccines Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size (2019-2030)
7.2 Europe Veterinary Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Vaccines Market Size by Country (2019-2024)
7.4 Europe Veterinary Vaccines Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size (2019-2030)
8.2 Asia-Pacific Veterinary Vaccines Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Vaccines Market Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Vaccines Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size (2019-2030)
9.2 Latin America Veterinary Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Vaccines Market Size by Country (2019-2024)
9.4 Latin America Veterinary Vaccines Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size (2019-2030)
10.2 Middle East & Africa Veterinary Vaccines Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Vaccines Market Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Vaccines Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Detail
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Vaccines Introduction
11.1.4 Elanco Revenue in Veterinary Vaccines Business (2019-2024)
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Vaccines Introduction
11.2.4 Merck Revenue in Veterinary Vaccines Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Detail
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Vaccines Introduction
11.3.4 Merial Revenue in Veterinary Vaccines Business (2019-2024)
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Detail
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Vaccines Introduction
11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2019-2024)
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Detail
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Vaccines Introduction
11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2019-2024)
11.5.5 Advaxis Recent Development
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Detail
11.6.2 AmpliPhi Biosciences Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2019-2024)
11.6.5 AmpliPhi Biosciences Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Detail
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2019-2024)
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Detail
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Introduction
11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2019-2024)
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Vaccines Introduction
11.9.4 Bayer Revenue in Veterinary Vaccines Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Detail
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2019-2024)
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva Animal Health
11.11.1 Ceva Animal Health Company Detail
11.11.2 Ceva Animal Health Business Overview
11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2019-2024)
11.11.5 Ceva Animal Health Recent Development
11.12 Colorado Serum
11.12.1 Colorado Serum Company Detail
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Vaccines Introduction
11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2019-2024)
11.12.5 Colorado Serum Recent Development
11.13 Epitopix
11.13.1 Epitopix Company Detail
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Vaccines Introduction
11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2019-2024)
11.13.5 Epitopix Recent Development
11.14 Genus
11.14.1 Genus Company Detail
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Vaccines Introduction
11.14.4 Genus Revenue in Veterinary Vaccines Business (2019-2024)
11.14.5 Genus Recent Development
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Detail
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2019-2024)
11.15.5 Hygieia Biological Laboratories Recent Development
11.16 ImmuCell
11.16.1 ImmuCell Company Detail
11.16.2 ImmuCell Business Overview
11.16.3 ImmuCell Veterinary Vaccines Introduction
11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2019-2024)
11.16.5 ImmuCell Recent Development
11.17 Nexvet
11.17.1 Nexvet Company Detail
11.17.2 Nexvet Business Overview
11.17.3 Nexvet Veterinary Vaccines Introduction
11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2019-2024)
11.17.5 Nexvet Recent Development
11.18 Nuovo Biologics
11.18.1 Nuovo Biologics Company Detail
11.18.2 Nuovo Biologics Business Overview
11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2019-2024)
11.18.5 Nuovo Biologics Recent Development
11.19 UBI
11.19.1 UBI Company Detail
11.19.2 UBI Business Overview
11.19.3 UBI Veterinary Vaccines Introduction
11.19.4 UBI Revenue in Veterinary Vaccines Business (2019-2024)
11.19.5 UBI Recent Development
11.20 Valneva
11.20.1 Valneva Company Detail
11.20.2 Valneva Business Overview
11.20.3 Valneva Veterinary Vaccines Introduction
11.20.4 Valneva Revenue in Veterinary Vaccines Business (2019-2024)
11.20.5 Valneva Recent Development
11.21 Vetoquinol
11.21.1 Vetoquinol Company Detail
11.21.2 Vetoquinol Business Overview
11.21.3 Vetoquinol Veterinary Vaccines Introduction
11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2019-2024)
11.21.5 Vetoquinol Recent Development
11.22 Virbac
11.22.1 Virbac Company Detail
11.22.2 Virbac Business Overview
11.22.3 Virbac Veterinary Vaccines Introduction
11.22.4 Virbac Revenue in Veterinary Vaccines Business (2019-2024)
11.22.5 Virbac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
